| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |